Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7317091 Optimized Fc variants

Patent 7317091 was granted and assigned to Xencor on January, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Xencor
Xencor
0
Date Filed
March 26, 2004
0
Date of Patent
January 8, 2008
0
Patent Application Number
10822231
0
Patent Citations Received
‌
US Patent 12134632 On-column viral inactivation methods
0
‌
US Patent 11987617 Antibodies that target HIV GP120 and methods of use
0
‌
US Patent 12006368 Anti-frizzled antibodies and methods of use
0
‌
US Patent 12017050 Drug depot delivery system and method
0
‌
US Patent 12018068 Anti-O1 antibodies and uses thereof
0
‌
US Patent 12024569 HER2/neu-specific antibodies and methods of using same
0
‌
US Patent 12076519 Drug delivery device and methods having a retaining member
0
‌
US Patent 12077790 Optimized binuclease fusions and methods
0
‌
US Patent 12084513 Anti-C1S antibodies and methods of use
0
‌
US Patent 12110338 Site-specific antibody-drug conjugation through glycoengineering
0
•••
Patent Inventor Names
Wei Dang
0
Arthur J. Chirino
0
Gregory Alan Lazar
0
John R. Desjarlais
0
Omid Vafa
0
Robert J. Hayes
0
Sher Bahadur Karki
0
Stephen Kohl Doberstein
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7317091
0
Patent Primary Examiner
‌
Phillip Gambel
0

Find more entities like US Patent 7317091 Optimized Fc variants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo